Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-11
DOI
10.1002/pbc.28798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rhabdomyosarcoma
- (2019) Stephen X. Skapek et al. Nature Reviews Disease Primers
- Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
- (2019) Emily Hibbitts et al. Cancer Medicine
- Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
- (2018) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information
- (2018) Christian Koelsche et al. MODERN PATHOLOGY
- MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification
- (2018) Narasimhan P. Agaram et al. MODERN PATHOLOGY
- English Translation of M. Bérard: Tumeur Embryonnaire Du Muscle Strié. [Embryonal Tumor of Striated Muscle]. Lyon Med 1894; 77: 52
- (2018) R. Beverly Raney et al. Fetal and Pediatric Pathology
- Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma
- (2018) Wenyue Sun et al. INTERNATIONAL JOURNAL OF CANCER
- Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group
- (2017) Erin R. Rudzinski et al. PEDIATRIC BLOOD & CANCER
- Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group
- (2016) Michael A. Arnold et al. PEDIATRIC BLOOD & CANCER
- The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2015) Erin R. Rudzinski et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Prognostic value of PAX3/7–FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis
- (2015) Tadahiko Kubo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma
- (2015) Wenyue Sun et al. MODERN PATHOLOGY
- Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
- (2015) Masafumi Seki et al. Nature Communications
- Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma
- (2014) Erin R. Rudzinski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- RecurrentMYOD1mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis
- (2014) Narasimhan P. Agaram et al. GENES CHROMOSOMES & CANCER
- Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
- (2014) J. F. Shern et al. Cancer Discovery
- Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma
- (2013) Erin R. Rudzinski et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- RecurrentNCOA2gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma
- (2013) Juan Miguel Mosquera et al. GENES CHROMOSOMES & CANCER
- PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- An English Translation of Joseph Luc Riopelle, MD, (Hôtel-Dieu of Montréal), and Jean Paul Thériault (Hôpital Général of Verdun, Québec, Canada): Sur une Forme Méconnue de Sarcome des Parties Molles: Le Rhabdomyosarcome Alvéolaire (Concerning an Unrecognized Form of Sarcoma of the Soft Tissues: Alveolar Rhabdomyosarcoma). Annales d'Anatomie Pathologique 1956;1:88–111.
- (2012) R. Beverly Raney et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS)
- (2011) Sabine Stegmaier et al. PEDIATRIC BLOOD & CANCER
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2β as biomarkers for rhabdomyosarcoma diagnostics
- (2009) Beate Grass et al. HISTOPATHOLOGY
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started